DJIA 17,001.22 -38.27 -0.22%
NASDAQ 4,538.55 6.45 0.14%
S&P 500 1,988.40 -3.97 -0.20%
market minute promo

Geron Corp (NASDAQ: GERN)

2.32 0.00 (0.00%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

GERN $2.32 0.00%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $2.31
Previous Close $2.32
Daily Range $2.30 - $2.35
52-Week Range $1.39 - $7.79
Market Cap $364.0M
P/E Ratio -9.28
Dividend (Yield) $0.00 (0.0%)
Volume 1,183,214
Average Daily Volume 2,563,173
Current FY EPS -$0.23





Geron Corp (GERN) Description

A biopharmaceutical company which is developing first-in-class therapeutic products for the treatment of cancer and chronic degenerative diseases, including spinal cord injury, heart failure, diabetes and HIV/AIDS. Website:

News & Commentary Rss Feed

3 Longtime Losers About to See Green?

These 3 biotechs have lost tons of money every year so far in the 21st century. But could profits be on the horizon?

Geron's (GERN) CEO John Scarlett on Q2 2014 Results - Earnings Call Transcript

Geron's (GERN) CEO John Scarlet on Q2 2014 Results - Earnings Call Transcript

Yellen, Icahn Comments Put a Lid on Small-Cap Stocks, May Hurt Larger Market

Stock Market Today: Social Media, Biotech Suffer as Janet Yellen Shares Concerns on Valuation

Better Buy: Dynavax Technologies Corp. vs. Geron Corp.

Dynavax Technologies Corp. and Geron Corp. have pending catalysts that could cause their shares to double from current levels. Here's a Foolish look at which company offers the better risk-to-reward profile.

Geron Corp. (GERN) Jumps: Stock Moves 8.1% Higher - Tale of the Tape

Geron (GERN) Enters Overbought Territory - Tale of the Tape

Will Investors Profit from Geron's Road to Recovery?

Geron gets a clinical hold released, but is still a ways away from competing with Incyte's Jakafi.

A Beaten-Down Biotech Stock Poised for an Epic Short Squeeze

See More GERN News...

GERN's Top Competitors

GERN $2.32 (0.00%)
Current stock: GERN
AMGN $132.82 (0.22%)
Current stock: AMGN
GILD $103.96 (1.65%)
Current stock: GILD
BIIB $339.97 (0.39%)
Current stock: BIIB